Welcome
Gary Disbrow, PhD; Director, BARDA
Ryan Vega, MD, MSHA; Chief Officer, Office of Healthcare
Innovation and Learning, VA
Expanding Patients’ Agency in Healthcare:
Technologies that Extend Healthcare to the Home Virtual Public
Meeting
The 2023 Federal Health-at-Home Technology Summit is supported by multiple federal agencies and intended to bring together diverse stakeholders to elevate the discussion on novel technologies that enable health assessment and monitoring at home. The Summit is open to the public and will address issues such as the perspectives of patients and their medical care providers, representatives of regulatory and payer organizations, and federal research funding agencies.
Thank you for joining us. We hope you enjoy the 2023 Federal Health-at-Home Technology Summit!
Gary Disbrow, PhD; Director, BARDA
Ryan Vega, MD, MSHA; Chief Officer, Office of Healthcare
Innovation and Learning, VA
Sandeep Patel, PhD; Director, BARDA DRIVe
Jay Newton-Small, MS; CEO and Founder, MemoryWell
Robert Quinn; CEO and Co-Founder, Patchd
Gene Wang; Chairman, Chief Scientist, and Co-Founder, Care Daily
Moderator: Dana Plude, PhD; Deputy Director, Division of Behavioral and Social Research, NIA
Blake Anderson, MD; Founder and CEO, Switchboard; Chief Health Informatics Officer, Atlanta VA Medical Center
Cole Zanetti, DO, MPH; Acting Director, Value Based Care, VA Center for Care and Payment Innovation
Moderator: Anne Bailey, PharmD, BCPS; Director, Clinical Tech Innovation, VA Office of Healthcare Innovation and Learning
Jennifer Goldsack, MChem, MA, MBA; Co-Founder and CEO, Digital Medicine Society
Susan Gregurick, PhD; Associate Director for Data Science and Director of the Office of Data Science and Strategy, NIH
Beth Jaworski, PhD; Social and Behavioral Sciences Administrator, NIH/Office of Behavioral and Social Sciences Research
Moderator: Šeila Selimović, PhD; Branch Chief, BARDA DRIVe
Matt Humbard, PhD; Testing and Diagnostics Domain Lead, HHS/ASPR
Barry Lutz, PhD; Associate Professor of Bioengineering, University of Washington
Sean Parsons, MBBS; Founder, CEO, and Managing Director, Ellume
Moderator: Gina Conenello, PhD; Program Officer, BARDA DRIVe
Bruce Greenstein, MS; Executive Vice President and Chief Strategy and Innovation Officer, LHC Group
William Padula, PhD; Assistant Professor of Pharmaceutical & Health Economics, University of Southern California
Mona Siddiqui, MD, MPH, MSE; Senior Vice President, Home Clinical Operations, CenterWell
Damien Soghoian, PhD; Partner, Global Health Investment Corporation
Arti Tandon, PhD; Digital Health Specialist, Digital Health Center of Excellence, Center for Devices and Radiological Health, FDA
Moderator: Kimberly Sciarretta, PhD; Branch Chief, BARDA DRIVe
Anne Bailey, PharmD, BCPS; Director, Clinical Tech Innovation, VA Office of Healthcare Innovation and Learning
Dana Plude, PhD; Deputy Director, Division of Behavioral and Social Research, NIA
Kimberly Sciarretta, PhD; Branch Chief, BARDA DRIVe
Moderator: Šeila Selimović, PhD; Branch Chief, BARDA DRIVe
Šeila Selimović, PhD; Branch Chief, BARDA DRIVe
Director // HHS/ASPR/BARDA
Deputy Assistant Secretary for Preparedness and Response //
HHS/ASPR
Dr. Disbrow joined BARDA in January of 2007 and has held a
variety of positions related to the advanced development and
procurement of medical countermeasures against an array of
threats to national security and public health. Prior to
becoming the BARDA Director, he served as acting BARDA
Director, Deputy Assistant Secretary of ASPR and Medical
Countermeasures Program Director. In October 2013, Dr. Disbrow
was named Acting Director of the Chemical, Biological,
Radiological and Nuclear (CBRN) Division and was subsequently
named the Director of the Division in December of 2014. During
that time, the CBRN Division built a robust pipeline of
candidate products under advanced research and development. In
2014 and 2015, Dr. Disbrow was identified as the Ebola
Incident Coordinator for BARDA and worked closely with the
BARDA Director on funding needs, development of candidate
products, and was the primary liaison for BARDA across the
Public Health Emergency Medical Countermeasures Enterprise
(PHEMCE). These efforts led to the first licensed Ebola
vaccine, ERBEVO licensed in December 2019. In October 2008,
Dr. Disbrow began serving as the Deputy Director of the CBRN
Division of Countermeasures and oversaw the budget and
programs for both advanced research and development and
Project BioShield efforts. Upon joining BARDA in January 2007,
he began working on the smallpox vaccine program. Dr. Disbrow
played a key role in awarding the first contract under Project
BioShield using the authorities for advanced payment and
milestone payments provided under the Pandemic and All-Hazards
Preparedness Act (2006). JYNNEOS was licensed in September
2019. Prior to joining BARDA, Dr. Disbrow was an Assistant
Professor of Oncology and Pathology at Georgetown Medical
Center where he worked on human papillomavirus (HPV) vaccines
and therapeutics. he has previously worked at W.R. Grace,
Kodak, and Genecor, and he attended the University of
Rochester and Georgetown University for his undergraduate and
PhD, respectively
Chief Officer, Healthcare Innovation and Learning // VA/VHA
Office of Discovery, Education & Affiliate Networks
Dr. Vega serves as the Chief Officer for the Office of
Healthcare Innovation and Learning as part of the VHA DEAN
Office (Discovery, Education and Affiliate Networks). In this
role, he has direct responsibility for (1) fostering the
discovery and spread of grassroots and strategic innovative
solutions, practices and products across VA; (2) advancement
of competencies in innovation and simulation through workforce
development; (3) combining the use of clinical simulation and
training to further enhance the utilization and uptake of
emerging healthcare technology in clinical practice; (4)
developing innovative approaches to testing payment and
service delivery models to reduce expenditures while
preserving or enhancing quality of care; and (5) advancing the
use of clinical training and simulation to advance VHA’s
mission of becoming a high reliability organization. Dr. Vega
holds academic appointments as an Adjunct Assistant Professor
in the Department of Health Administration at Georgetown
University as well as a Clinical Assistant Professor of
Medicine at George Washington University. Prior to his current
position, Dr. Vega served as the Chief Quality Officer at the
Richmond VA Medical Center and Assistant Professor of Medicine
at the VCU Health System. He also recently served for two
years as the Chair of the National Quality, Safety, and Value
Council for the Electronic Health Record Modernization (EHRM)
effort. Dr. Vega completed his residency training in internal
medicine at the VCU Health System in 2015 where he also served
as Chief Medical Resident and the VA Chief Resident for
Quality and Safety. With eight years of clinical training and
experience, Dr. Vega is board certified in Internal Medicine
and has been involved in research and practice in the areas of
health informatics, clinical quality improvement, patient
safety, and clinical innovation and implementation. He is a
graduate of the Intermountain Advanced Training Program in
Clinical Quality Improvement and his partnerships extend to
work with VA clinical and non-clinical leaders across the
health care system, including non-VA external stakeholders
across the nation. Dr. Vega is a recipient of several awards
for his work in healthcare innovation and has published
numerous articles on this topic.
Founder and CEO // Switchboard, MD
Chief Health Informatics Officer // Atlanta VA Medical Center
Dr. Anderson is an internal medicine physician and the Atlanta
VA Chief Health Informatics Officer. He received his medical
doctorate from Emory University School of Medicine and then
completed one year of residency training in general surgery at
the University of Florida before shifting gears and completing
a residency in internal medicine at Emory University School of
Medicine. After internal medicine residency he was the Chief
Resident in Quality and Patient Safety in 2016 at the Atlanta
VA. His clinical work has been outpatient internal medicine at
Emory and inpatient at the Atlanta VA. His research focuses on
predictive models generated from large, structured datasets in
addition to development and clinical deployment of natural
language processing algorithms. In addition to developing AI
solutions on his own, he is a thought leader in advanced data
methods including natural language processing with a special
focus on real time clinical workflow integration.
Director, Clinical Tech Innovation // VA Office of Healthcare
Innovation and Learning (OHIL) Immersive Technology Lead // VA
OHIL
Dr. Bailey is a board-certified pharmacotherapy specialist,
Director for Clinical Tech Innovation, and Immersive
Technology Lead for VA’s Office of Healthcare Innovation and
Learning (OHIL). Dr. Bailey started her healthcare journey as
a pharmacy resident and then pharmacy practitioner for Western
North Carolina VA Healthcare System in Asheville, NC. In 2020,
she joined the OHIL team to lead implementation of emerging
technology with a special focus on immersive tech. She has
collaborated with experts and thought leaders in government,
academia, and industry, while co-leading the expansion of the
VHA XR Network from the founding five facilities to over 160,
engaging more than 1,250 VA employees. Recently, Dr. Bailey
was awarded 2022 G2Xchange Change Agent Award and, along with
other OHIL Immersive Tech team members, the 2022 Service to
the Citizen Award. In October 2022, she received the
International Virtual Reality in Healthcare Association’s 2022
Hero Award for dedication to the growth of immersive
technology in healthcare.
Program Officer // HHS/ASPR/BARDA/DRIVe
Dr. Conenello is a virologist who received her PhD from Mount
Sinai School of Medicine. She started her career at FDA as a
Commissioner’s Fellow in CBER, later moving to CDRH as a
medical device lead reviewer for microbiology diagnostics for
9 years. Dr. Conenello is a subject matter expert
in point of care and home use diagnostics (including home
collection kits) with a focus on respiratory diagnostics, and
STI diagnostics. During the pandemic she was instrumental
in the EUA authorizations for the first home collection kits
and home use tests for SARS-COV-2. She joined BARDA DRIVe in
2022 to focus on de-risking cutting edge technologies,
developing novel regulatory strategies and facilitating
decentralized care modalities for pandemic response.
Co-Founder and CEO // Digital Medicine Society (DiMe)
Jennifer C. Goldsack co-founded and serves as the CEO of the
Digital Medicine Society (DiMe), a 501(c)(3) non-profit
organization dedicated to advancing digital medicine to
optimize human health. Her research focuses on applied
approaches to the safe, effective, and equitable use of
digital technologies to improve health, healthcare, and health
research. Jen is a member of the Roundtable on Genomics and
Precision Health at the National Academies of Science,
Engineering and Medicine. Previously, she spent several years
at the Clinical Trials Transformation Initiative (CTTI), a
public-private partnership co-founded by Duke University and
the FDA. There, she led development and implementation of
several projects within CTTI’s Digital Program and was the
operational co-lead on the first randomized clinical trial
using FDA’s Sentinel System. Jen spent five years working in
research at the Hospital of the University of Pennsylvania,
first in Outcomes Research in the Department of Surgery and
later in the Department of Medicine. More recently, she helped
launch the Value Institute, a pragmatic research and
innovation center embedded in a large academic medical center
in Delaware. Jen earned her master’s degree in chemistry from
the University of Oxford, England, her masters in the history
and sociology of medicine from the University of Pennsylvania,
and her MBA from the George Washington University.
Additionally, she is a certified Lean Six Sigma Green Belt and
a Certified Professional in Healthcare Quality. Jen is a
retired athlete, formerly a Pan American Games Champion,
Olympian, and World Championship silver medalist.
Executive Vice President and Chief Strategy and Innovation
Officer // LHC Group
Bruce Greenstein currently serves as Executive Vice President
and Chief Strategy and Innovation Officer at LHC Group, Inc.
With his role as Chief Strategy Officer, Bruce leads the
Company’s accelerated value-based contracting, Accountable
Care Organization (ACO) management company and alternative
payment and delivery model strategies. Previously, Bruce
served as Chief Technology Officer for the U.S. Health and
Human Services (HHS) where he provided leadership and
direction to ensure that HHS effectively used data,
technology, and innovation to improve the lives of the
American people and the performance of the operating divisions
across the Department. He has an extensive healthcare industry
background in both government and the private sector,
including having served as President-West for Quartet Health,
CEO of Blend Health Insights, and as Managing Director of
Worldwide Health for Microsoft. Bruce was also a cabinet
member in Louisiana, serving as Secretary of the Department of
Health and Hospitals.
Associate Director for Data Science // HHS/NIH Director //
HHS/NIH Office of Data Science and Strategy
Dr. Gregurick was appointed Associate Director for Data
Science and Director of the Office of Data Science Strategy
(ODSS) at the National Institutes of Health on Sept. 16, 2019.
Under Dr. Gregurick’s leadership, the ODSS leads the
implementation of the NIH Strategic Plan for Data Science
through scientific, technical, and operational collaboration
with the institutes, centers, and offices that comprise NIH.
Dr. Gregurick was instrumental in the creation of the ODSS in
2018 and served as a senior advisor to the office until being
named to her current position. She was previously the Division
Director for Biophysics, Biomedical Technology, and
Computational Biosciences at the National Institute of General
Medical Sciences. Prior to joining the NIH in 2013, Dr.
Gregurick was a program director in the Office of Biological
and Environmental Research at the Department of Energy. Before
beginning a career of government service, Dr. Gregurick was a
professor of computational chemistry at the University of
Maryland, Baltimore County. Her research interests included
dynamics of large biological macromolecules, and her areas of
expertise are computational biology, high performance
computing, neutron scattering and bioinformatics. Dr.
Gregurick received her undergraduate degree in chemistry and
mathematics from the University of Michigan and her PhD in
physical chemistry from the University of Maryland.
Testing and Diagnostics Domain Lead // HHS/ASPR Industrial
Base Management & Supply Chain Program Office
Dr. Humbard is the Testing and Diagnostics Domain Lead in
Industrial Base Management & Supply Chain Group at ASPR. He
helped lead the industry engagement team as part of the DHHS
Testing and Diagnostics Working Group during the COVID-19
pandemic. Prior to the pandemic, Dr. Humbard was a lead
reviewer and consumer safety officer at the Food and Drug
Administration in the Office of In Vitro Diagnostics and
Radiological Health. He received his PhD in microbiology and
cell biology from the University of Florida in 2009.
Social and Behavioral Sciences Administrator // HHS/NIH/Office
of Behavioral and Social Sciences Research (OBSSR)
Dr. Jaworski joined the Office of Behavioral and Social
Sciences Research (OBSSR) at the National Institutes of Health
as a Social and Behavioral Sciences Administrator in September
2021. In this role, she supports the OBSSR mission to enhance
the impact of health-related behavioral and social sciences
research, coordinate and integrate these sciences within the
larger NIH research enterprise, and communicate health-related
behavioral and social sciences research findings. Dr. Jaworski
earned her PhD in social psychology from the University of
California, Santa Cruz and her bachelor’s degree in psychology
from the University of Wisconsin, Madison. Prior to joining
OBSSR, she served as the mobile user experience (UX) lead at
the VA’s National Center for PTSD, Dissemination and Training
Division, where she split her time between creating and
researching public mental health apps for PTSD and related
conditions. Dr. Jaworski's research interests are focused on
how the social and behavioral sciences can be leveraged to
design and implement impactful and engaging digital health
interventions. She is especially interested in mixed methods
approaches that center health equity and inclusion, take
social context into account, and explore innovative ways to
deliver and integrate health information, across a range of
settings.
Associate Professor of Bioengineering // University of
Washington
Dr. Lutz is an Associate Professor of Bioengineering at the
University of Washington, where his research focuses on
point-of-care diagnostics for infectious diseases, and he
teaches courses on molecular diagnostics, global health
technology, engineering design, and technology
commercialization. Dr. Lutz worked with his mentor Prof. Paul
Yager and contemporary Prof. Elain Fu to develop foundational
technology in paper-based microfluidics, and more recently his
group has focused on high-quality point-of-care tests for
diseases including HIV, TB, COVID-19, and influenza. He was a
Co-PI in the Seattle Flu Study, where he partnered with Dr.
Matthew Thompson on studies to evaluate performance of home
testing for influenza, and pivoted to deliver home test kits
in the early days of the COVID-19 pandemic to support public
health surveillance. He is Co-Founder and Chief Scientific
Officer for Anavasi Diagnostics, which was founded in response
to the pandemic to develop low-cost, high-performance tests
for COVID-19 and other diseases.
CEO and Founder // MemoryWell
Jay Newton-Small is CEO and founder of MemoryWell, a national
network of more than 800 writers who tell the life stories of
seniors to help improve their care. Previously, Jay was
Washington correspondent for TIME Magazine, where she remains
a contributor. At TIME she covered politics as well as stories
on five continents from conflicts in the Middle East to the
earthquake in Haiti and the November 2015 Paris terror
attacks. She has written nearly a dozen TIME cover stories and
interviewed numerous heads of state, including Presidents
Barack Obama and George W. Bush. She authored the 2016
best-selling book, Broad Influence: How Women Are Changing the
Way America Works. Before TIME, Jay was a reporter for
Bloomberg News, where she covered the White House and
politics. She received an MS in journalism from Columbia
University and undergraduate degrees in International
Relations and Art History from Tufts University. She is a 2017
Halcyon Incubator fellow, a 2016-2017 New America fellow and a
2015 Harvard Institute of Politics fellow. She is also the
2016 winner of the prestigious Dirksen Award for congressional
reporting and the 2016 Deadline Club award for community
service reporting.
Assistant Professor of Pharmaceutical & Health Economics //
School of Pharmacy, University of Southern California (USC)
Fellow // Leonard D. Schaeffer Center for Health Policy and
Economics (USC)
Dr. Padula is Assistant Professor of Pharmaceutical & Health
Economics in School of Pharmacy and a Fellow in the Leonard D.
Schaeffer Center for Health Policy and Economics at the
University of Southern California (USC) in Los Angeles, CA. He
holds adjunct appointments at Johns Hopkins University in the
School of Nursing and the Armstrong Institute for Patient
Safety and Quality at Hopkins Medicine in Baltimore, MD. His
research explores the theoretical foundations of medical
cost-effectiveness analysis, especially pertaining to issues
around the value of vaccines, healthcare delivery and patient
safety in hospitals for acquired conditions such as pressure
injuries. Dr. Padula currently serves as President for the
U.S. National Pressure Injury Advisory Panel (NPIAP). He was
also Commissioner for the American Nurses Credentialing Center
(ANCC) Magnet® Recognition Program from 2016-2019. He is the
Associate Editor of Value in Health and serves on the
editorial boards of Applied Health Economics and Health Policy
and Journal of Clinical Nursing, and is a past recipient of
several awards from the International Society of
Pharmacoeconomics and Outcomes Research (ISPOR). Dr. Padula
was a visiting scholar at the University of York Centre for
Health Economics in York, UK, the Oxford Institute for
Nursing, Midwifery and Allied Health in Oxford, UK, and the
University of Technology Sydney in Sydney, Australia. He
received his BS in Chemical Engineering from Northwestern
University, MS in Evaluative Clinical Science from Dartmouth
College, MS in Data Analytics from University of Chicago, and
PhD in Pharmaceutical Economics from University of
Colorado.
Founder, CEO, and Managing Director // Ellume
Dr. Parsons is a clinically trained business leader with a
track record of successfully developing breakthrough medical
technologies and leading the product commercialization for the
benefit of human health. He is the Founder, CEO and Managing
Director of Ellume and serves in dual commercial and technical
capacities in the company. He is a co-inventor of Ellume’s
core pioneering quantum dot detection system technology and is
named in over 40 patents and papers. Dr. Parsons has provided
the strategic vision for the company in the digital health
technology space and has led the negotiation and execution of
all major partnerships and collaborations. Previously, he was
a critical care clinician with post-graduate training in
emergency and intensive care medicine, working in major
metropolitan hospitals in Queensland, Australia. Dr. Parsons
holds a BS, Dual Major – Physiology and Biomedical Science
with First Class Honors from the University of Queensland, and
an MBBS also from the University of Queensland. He is a
graduate of the Australian Institute of Company
Directors.
Director // HHS/ASPR/BARDA/DRIVe
Dr. Patel, oversees a diverse portfolio of health security
innovations to address current and emerging threats. He is an
entrepreneur and restless innovator who uses his experience to
advance high impact science, build new products, and launch
new programs and initiatives that focus on health and
wellness. His experiences highlight his commitment to public
service as evidenced in his prior roles in the US Department
of Health and Human Services (HHS) where he focused on
advancing innovative policies and funding solutions to
complex, long-standing health-related problems. He cofounded
and led a new $35M+ public-private partnership, KidneyX, that
advanced development and lowered the commercialization risks
of breakthrough therapies for kidney disease, notably an
implantable artificial kidney to displace dialysis. He
spearheaded the Advancing American Kidney Health Initiative
and he built a $50M program scaling the use of incentive
prizes and crowdsourcing as 21st century problem-solving tools
across the family of HHS agencies. Previously, Dr. Patel
served in a number of science policy roles, including as a
Mirzayan Science and Technology Policy Fellow at the National
Academy of Sciences and as a scientific consultant for Thomson
Reuters. He is the recipient of the American Society of
Nephrology’s President’s Medal, honoring those who have
transformed kidney care, for which he was also awarded a
Secretary’s Distinguished Service award. He founded a company
in Uganda focused on rapid design and development of novel
products for agriculture and health using portable 3D printing
services. He holds a PhD in physical chemistry from the
Georgia Institute of Technology and a BA in chemistry from
Washington University in St. Louis.
Deputy Director // HHS/NIH/National Institute on
Aging/Division of Behavioral and Social Research
Dr. Plude is Deputy Director in the Division of Behavioral and
Social Research (DBSR) where he also manages a research
portfolio on cognitive aging. Prior to joining NIA in December
2016, he served as Associate Director and Research/Review
Integrity Officer in the Division of Receipt & Referral in the
Center for Scientific Review (CSR) before which he was Chief
of the Bio-behavioral and Behavioral Processes Integrated
Review Group (BBBP IRG) and Scientific Review Officer for the
Cognition and Perception study section. Before joining CSR in
2002, he was Associate Professor and Associate Chair in
Psychology at the University of Maryland – College Park for 17
years. He earned a PhD in Psychology from Syracuse University,
where he specialized in lifespan development and mental
function in the elderly.
CEO and Co-Founder // Patchd
Robert Quinn is the CEO and Co-founder of Patchd, Inc. He has
been a founder for the last 6 years focused on solving sepsis.
Prior to starting Patchd, Robert worked for Telstra, one of
Australia's largest technology companies in their Chief
Technology Office. He is not only a survivor of over 18
episodes of sepsis, but studied both Biomedical science
majoring in Neuroscience and Mechatronic engineering. His goal
is to help ensure patients no longer die from sepsis at
home.
Branch Chief // HHS/ASPR/BARDA/DRIVe
Dr. Sciarretta is the Branch Chief for DRIVe’s Launch Office
and leads the Host-Based Diagnostics, the Host-directed
Therapeutics, and the Healthcare Infrastructure,
Implementation, and Impact (HI-3) programs. Dr. Sciarretta has
been with BARDA since 2015, and was one of inaugural members
of DRIVe, influencing the vision and growth of the Division.
Prior to BARDA, she had extensive experience within the
Department of Defense and other US Government Agencies as a
technical consultant, focusing on biological and chemical
defense as well as leading innovation in areas including
synthetic biology and advanced manufacturing. Dr. Sciarretta
strives towards building and piloting new strategic approaches
to support agile preparedness for public health emergencies
and to improve patient outcomes. Dr. Sciarretta received her
PhD from the University of Chicago in Molecular Genetics and
Cell Biology.
Branch Chief // HHS/ASPR/BARDA/DRIVe
Dr. Selimović oversees multiple programs in BARDA/DRIVe that
focus on de-risking transformational technologies in the
health security space, towards the goal of making medical
countermeasures more widely and easily accessible – from Lab
at Home to Digital Medical Countermeasures. Prior to BARDA,
she was a Program Director at the National Institute of
Biomedical Imaging and Bioengineering, working in the sensors
and tissue engineering areas, and a AAAS Science and
Technology Policy Fellow at the US Department of State, where
she helped spearhead the first U.S.-Poland Innovation
Partnership. Dr. Selimović completed her PhD in Condensed
Matter Physics at Brandeis University, funded by an NSF
Traineeship, and pursed a postdoctoral fellowship at Harvard
Medical School / Brigham & Women’s Hospital.
Senior Vice President, Home Clinical Operations // CenterWell
Dr. Siddiqui is Senior Vice President for Home Clinical
Operations at CenterWell where she is leading the development
and implementation of its value-based care model. For three
years prior to this, she was Senior Vice President for
Enterprise Clinical Strategy and Quality across the Insurance
segment where she led the development and management of
Humana’s enterprise clinical strategy and provided direction
for clinical quality in an effort to drive continued
improvements in health outcomes for patients. Dr. Siddiqui
most recently served at the U.S. Department of Health and
Human Services as the Department’s inaugural Chief Data
Officer. In that role, she led the effort to connect the
nation’s health care data through the build-out of an
enterprise-wide data-sharing technology platform, governance
structure and advanced the Department’s Artificial
Intelligence strategy. Previously, Dr. Siddiqui served at the
Centers for Medicare and Medicaid Innovation implementing new
payment models and technology enabled solutions. She has also
served with the White House Social and Behavioral Sciences
Team (“nudge” unit) during the Obama administration working
with ONC, CMS, FDA, VA and DHA on operationalizing insights
from behavioral economics in large scale government programs
to improve efficiency and effectiveness. Prior to her work in
the federal government, Dr. Siddiqui was at the Johns Hopkins
University Health System where she was focused on driving
value-based care initiatives. Dr. Siddiqui holds a medical
degree from the Johns Hopkins University School of Medicine, a
master’s degree in Quantitative Methods from the Harvard
School of Public Health, and a degree in Management and
Engineering from Stanford University. She completed her
undergraduate work in neuroscience and philosophy from the
University of Maryland where she graduated summa cum laude and
the class Valedictorian.
Digital Health Specialist // HHS/FDA/Center for Devices and Radiological Health (CDRH) /Digital Health Center of Excellence
Dr. Tandon is a Digital Health Specialist in the Center for Devices and Radiological Health’s (CDRH) Digital Health Center of Excellence and has been with FDA since 2021. She has extensive research and product development experience in the life sciences industry across academic, large corporate and startup environments. Prior to joining the Digital Health team at FDA, Dr. Tandon was the Vice President of Precision Nutrition at Astarte Medical, a digital health startup where she developed the business plan and product strategy for a preterm precision nutrition platform. Earlier, Dr Tandon was a product owner at Philips Research North America of genomics and informatics clinical decision support tools for cancer and Hereditary diseases for a cloud-based software platform providing precision diagnostics and therapy guidance. Prior to that she was a core bioinformatics scientist at Harvard Medical School with research focusing on theoretical and experimental work in ancient DNA, human population history and medical genetics. Dr. Tandon has contributed to 20+ high impact publications in population and medical genetics and received a BSc and MSc in Physics from Indian Institute of Technology, Kharagpur, India, as well as a PhD in Physics from Boston University.
Partner // Global Health Investment Corporation
Dr. Soghoian is a Partner on the Investment team at the Global
Health Investment Corporation (GHIC). Previously, he was a
Director at Foresite Capital Management and Head of Strategy
and Operations at Foresite Labs. Damien was an early employee
at Verily Life Sciences (formerly Google Life Sciences), where
he was technical lead for Verily’s population scale immune
observatory platform and Project Baseline, a distributed
clinical trial solution. At Foresite, he focused on investing
in early stage life science and healthcare companies and
helped found and run the firm’s incubator, Foresite Labs,
where he was part of the leadership team and focused on the
incubation of new healthcare and biotechnology companies that
use the tools of data science to solve unmet medical needs.
Damien has a PhD in Virology from Harvard University and is a
founding member of the Alliance to End Biological Risks at the
Council on Strategic Risks (CSR).
Acting Director, Value-Based Care // VA Center for Care and
Payment Innovation
Dr. Zanetti is the Acting Director for Value-Based Care in the
VA Center for Care and Payment Innovation (CCPI). In this
role, Dr. Zanetti is leading the CCPI’s efforts in value-based
care in the VA and within the community. Dr. Zanetti is triple
board-certified in family medicine, preventative medicine, and
clinical informatics. He has also been trained in value-based
health care, community organizing and positive deviance. Dr.
Zanetti has served as the senior advisor to the VHA Innovation
Ecosystem, a chief health informatics officer for the Ralph H.
Johnson VA as well as a primary care section chief at the
Eastern Colorado VA. He also served as a primary care
innovator with Iora Health. Dr. Zanetti earned his DO at the
University of North Texas Health Science Center – Texas
College of Osteopathic Medicine, his MPH at the Dartmouth
Institute for Health Policy and Clinical Practice, and his BA
in Psychology at the University of Buffalo. Dr. Zanetti
completed his family medicine residency training at NH
Dartmouth and his leadership preventative medicine residency
training at Dartmouth Hitchcock Medical Center.
Chairman, Chief Scientist, and Co-Founder // Care Daily
Gene Wang is a technology entrepreneur with relentless
determination. He is a 4-time CEO who led Computer Motion, a
leader in surgical robotics, through a successful IPO. He next
founded Photo Access, a digital imaging startup purchased by
Agilent, who’s technology powered 100 million digital camera
phones. Gene founded Bitfone, a mobile device management
company which enabled over-the-air firmware updates in 300
million mobile phones and was acquired by Hewlett-Packard.
Today, he is leading the research and development of
next-generation senior care services as Principal Investigator
for six caregiver studies with generous funding from the U.S.
National Institute on Aging. Gene received his BA in Computer
Science from the University of California at Berkeley. He
leads the Daily Beats Band and plays saxophone and flute. He
is happily married with three wonderful children and two bad
dogs.